Literature DB >> 8233829

A novel transforming growth factor-beta 1 responsive cytoplasmic trans-acting factor binds selectively to the 3'-untranslated region of mammalian ribonucleotide reductase R2 mRNA: role in message stability.

F M Amara1, F Y Chen, J A Wright.   

Abstract

Ribonucleotide reductase is a highly regulated enzyme that provides the four deoxyribonucleotides required for DNA synthesis. Our studies showed that TGF-beta 1 treatment of BALB/c 3T3 mouse fibroblasts markedly elevated ribonucleotide reductase R2 mRNA levels, and also increased the half-life of R2 message by 4-fold from 1.5 h in untreated cells to 6 h in treated cells. We describe a novel 75 Kd sequence-specific cytoplasmic factor (p75) that binds selectively to a 83-nucleotide 3'-untranslated region of R2 mRNA and did not bind to the 5'UTR, the coding region of the R2 message or to the 3'UTRs of other mRNAs (from c-myc, GM-CSF and the iron responsive element from the transferrin receptor mRNA), or to the homopolymer poly(A) sequence. p75-RNA binding activity, which requires new protein synthesis, is not present in untreated cells, but is induced following TGF-beta 1 stimulation. The in vivo kinetics of appearance of p75 binding activity paralleled the accumulation of R2 mRNA. Insertion of the 3'-untranslated region into the chloramphenicol acetyltransferase (CAT) message confers TGF-beta 1 induced stability of RNA in stably transfected cells, while the same insert carrying a deletion of the 83-nucleotide fragment had little affect on RNA levels. Furthermore, in vitro decay reactions that contained the 83-nucleotide RNA or deletion of this fragment caused a significant decrease in TGF-beta 1 stabilization of R2 message. A model is presented of R2 message regulation in which TGF-beta 1 mediated stabilization of R2 message involves a specific interaction of a p75-trans-acting factor with a cis-element(s) stability determinant within the 83-nucleotide sequence which is linked to a reduction in the rate of R2 mRNA degradation.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8233829      PMCID: PMC331509          DOI: 10.1093/nar/21.20.4803

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  30 in total

1.  Regulation of mammalian ribonucleotide reductase by the tumor promoters and protein phosphatase inhibitors okadaic acid and calyculin A.

Authors:  R A Hurta; J A Wright
Journal:  Biochem Cell Biol       Date:  1992 Oct-Nov       Impact factor: 3.626

2.  Induction of c-sis mRNA and activity similar to platelet-derived growth factor by transforming growth factor beta: a proposed model for indirect mitogenesis involving autocrine activity.

Authors:  E B Leof; J A Proper; A S Goustin; G D Shipley; P E DiCorleto; H L Moses
Journal:  Proc Natl Acad Sci U S A       Date:  1986-04       Impact factor: 11.205

3.  Transforming growth factor beta increases mRNA for matrix proteins both in the presence and in the absence of changes in mRNA stability.

Authors:  R P Penttinen; S Kobayashi; P Bornstein
Journal:  Proc Natl Acad Sci U S A       Date:  1988-02       Impact factor: 11.205

4.  Sensitivity to melphalan as a function of transport activity and proliferative rate in BALB/c 3T3 fibroblasts.

Authors:  R Blosmanis; J A Wright; G J Goldenberg
Journal:  Cancer Res       Date:  1987-03-01       Impact factor: 12.701

5.  A nuclear factor 1 binding site mediates the transcriptional activation of a type I collagen promoter by transforming growth factor-beta.

Authors:  P Rossi; G Karsenty; A B Roberts; N S Roche; M B Sporn; B de Crombrugghe
Journal:  Cell       Date:  1988-02-12       Impact factor: 41.582

6.  Transcriptional regulation of two serum-induced RNAs in mouse fibroblasts: equivalence of one species to B2 repetitive elements.

Authors:  D R Edwards; C L Parfett; D T Denhardt
Journal:  Mol Cell Biol       Date:  1985-11       Impact factor: 4.272

7.  Assay of ribonucleotide reduction in nucleotide-permeable hamster cells.

Authors:  W H Lewis; B A Kuzik; J A Wright
Journal:  J Cell Physiol       Date:  1978-03       Impact factor: 6.384

8.  Replacement of insulin receptor tyrosine residues 1162 and 1163 compromises insulin-stimulated kinase activity and uptake of 2-deoxyglucose.

Authors:  L Ellis; E Clauser; D O Morgan; M Edery; R A Roth; W J Rutter
Journal:  Cell       Date:  1986-06-06       Impact factor: 41.582

9.  TGF-beta inhibition of endothelial cell proliferation: alteration of EGF binding and EGF-induced growth-regulatory (competence) gene expression.

Authors:  K Takehara; E C LeRoy; G R Grotendorst
Journal:  Cell       Date:  1987-05-08       Impact factor: 41.582

10.  Isolation of the oncogene and epidermal growth factor-induced transin gene: complex control in rat fibroblasts.

Authors:  L M Matrisian; P Leroy; C Ruhlmann; M C Gesnel; R Breathnach
Journal:  Mol Cell Biol       Date:  1986-05       Impact factor: 4.272

View more
  13 in total

1.  Defining a novel ribonucleotide reductase r1 mRNA cis element that binds to an unique cytoplasmic trans-acting protein.

Authors:  F Y Chen; F M Amara; J A Wright
Journal:  Nucleic Acids Res       Date:  1994-11-11       Impact factor: 16.971

2.  Highly conserved RNA sequences that are sensors of environmental stress.

Authors:  A Spicher; O M Guicherit; L Duret; A Aslanian; E M Sanjines; N C Denko; A J Giaccia; H M Blau
Journal:  Mol Cell Biol       Date:  1998-12       Impact factor: 4.272

Review 3.  mRNA stability in mammalian cells.

Authors:  J Ross
Journal:  Microbiol Rev       Date:  1995-09

4.  Identification and characterization of a 44 kDa protein that binds specifically to the 3'-untranslated region of CYP2a5 mRNA: inducibility, subcellular distribution and possible role in mRNA stabilization.

Authors:  O Geneste; F Raffalli; M A Lang
Journal:  Biochem J       Date:  1996-02-01       Impact factor: 3.857

5.  A binding factor for interleukin 2 mRNA.

Authors:  J Hua; V Paetkau
Journal:  Nucleic Acids Res       Date:  1996-03-01       Impact factor: 16.971

6.  An open reading frame element mediates posttranscriptional regulation of tropoelastin and responsiveness to transforming growth factor beta1.

Authors:  M Zhang; R A Pierce; H Wachi; R P Mecham; W C Parks
Journal:  Mol Cell Biol       Date:  1999-11       Impact factor: 4.272

7.  RNA-dependent inhibition of ribonucleotide reductase is a major pathway for 5-azacytidine activity in acute myeloid leukemia.

Authors:  Josephine Aimiuwu; Hongyan Wang; Ping Chen; Zhiliang Xie; Jiang Wang; Shujun Liu; Rebecca Klisovic; Alice Mims; William Blum; Guido Marcucci; Kenneth K Chan
Journal:  Blood       Date:  2012-04-19       Impact factor: 22.113

8.  Sequence-specific inhibition of gene expression by a novel antisense oligodeoxynucleotide phosphorothioate directed against a nonregulatory region of the human immunodeficiency virus type 1 genome.

Authors:  M I Anazodo; M A Wainberg; A D Friesen; J A Wright
Journal:  J Virol       Date:  1995-03       Impact factor: 5.103

9.  Novel inherited mutations and variable expressivity of BRCA1 alleles, including the founder mutation 185delAG in Ashkenazi Jewish families.

Authors:  L S Friedman; C I Szabo; E A Ostermeyer; P Dowd; L Butler; T Park; M K Lee; E L Goode; S E Rowell; M C King
Journal:  Am J Hum Genet       Date:  1995-12       Impact factor: 11.025

10.  Regulation of mammalian ribonucleotide reductase R1 mRNA stability is mediated by a ribonucleotide reductase R1 mRNA 3'-untranslated region cis-trans interaction through a protein kinase C-controlled pathway.

Authors:  F Y Chen; F M Amara; J A Wright
Journal:  Biochem J       Date:  1994-08-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.